Clinical Trials
4 trialsNCT07101159 2025-08-03
Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT03024580 2019-08-15
MEGA
Instituto Nacional de Cancer, Brazil
Phase 2 Unknown
NCT03497702 2018-04-13
NeoChAI
National Cancer Center, Korea
Phase 2 Unknown
NCT00532272 2011-06-27
Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBC
National Cancer Center, Korea
Phase 2 Completed